We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Swiss drugmaker Roche has launched a campaign in the U.S. urging businesses to stockpile its antiviral drug Tamiflu, despite a backlog of orders from world governments building emergency caches for the public as a hedge against a deadly flu pandemic.
Britain's pharmaceutical industry has proposed strict new guidelines for testing some experimental drugs after the disastrous trial of TeGenero's TGN1412 in March that left six men in comas.
India's Union Commerce Ministry has warned against any increase in price controls on drugs as they can indirectly affect the export performance of the domestic pharmaceutical industry.
Biotech company Pharming Group N.V. ("Pharming" or "the Company") (PHARM.AS) announced it has submitted the Marketing Authorization Application (MAA) for recombinant human C1 inhibitor (rhC1INH) to the European Medicines Agency (EMEA) for the treatment of acute attacks of hereditary angioedema (HAE).
Bangladesh has adopted the National Policy Guidelines on Biotechnology to accelerate multidimensional research for food security, health and environment.
Diethelm Holding (Malaysia) Bhd's unit Diethelm Malaysia Sdn Bhd has teamed up with Taisho Pharmaceutical Co Ltd, a leading Japaneses over-the-counter (OTC) healthcare manufacturer, to distribute the latter's products in the Malaysian market.
Biogen Idec and Elan Corporation, plc announced the commercial availability of TYSABRI (natalizumab) for the treatment of relapsing forms of multiple sclerosis (MS) in the U.S.
Tanabe Seiyaku launched Methotrexate tablets 2 mg TANABE (generic name: methotrexate), an anti-rheumatic drug for the indication of rheumatoid arthritis (RA) only if there is no indication of improvement when conventional treatment therapies such as nonsteroidal anti-inflammatory agents and other anti-rheumatic agents are used.
Fake China-made malaria drugs, which have flooded parts of Asia and killed many people in recent years, are beginning to show up in Africa where the dummy tablets are expected to take far more lives, a WHO expert has warned.